NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines

Latest News & Postscripts

Buprenorphine prescribing

Posted: May 05, 2017.
Category - Medicines Update
Tagged with - Opioids

The NHSGGC Substitute Prescribing Management Group has decided to change from Suboxone® (buprenorphine and naloxone) to generic single agent buprenorphine 0.4mg, 2mg and 8mg sublingual tablets across all Addiction servic...

Read More...

MHRA Updates March and April 2017

Posted: May 04, 2017.
Category - Medicines Update

Drug Safety Update (April 2017) includes: Valproate and neurodevelopmental...

Read More...

Adding hospital medicines to GP practice systems

Posted: May 04, 2017.
Category - Medicines Update

Within General Practice, it is beneficial to ensure that a patient's medicine record includes medicines that may be prescribed and supplied outwith the GP practice, such as the acute sector, community mental health teams. Examples of drugs...

Read More...

Hypoglycaemia treatment with sugary drinks

Posted: May 04, 2017.
Category - Medicines Update
Tagged with - Diabetes

In response to the forthcoming “Sugar Tax” levy on the production of sugary drinks, many manufacturers are significantly reducing the amount of sugar in their products. This has implications for diabetics who may use drinks, most co...

Read More...

Adult Therapeutics Handbook: Content update May 2017

Posted: May 03, 2017.
Category - Medicines Update Acute

The Therapeutics Handbook content has been updated and includes the following main changes: Resuscitation and Anaphylaxis section:The Management of Major Haemorrhage guideline has been updated to reflect current practices an...

Read More...

Formulary Update (April 2017)

Posted: May 02, 2017.
Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.

Read More...

Dabigatran: colour change

Posted: April 25, 2017.
Category - Medicines Update

The manufacturer of dabigatran (Pradaxa®) has written to healthcare professionals to advise that the colour of the capsule is being changed in a move that is likely to improve patient safety.   Dabig...

Read More...

Sacubitril / valsartan

Posted: April 25, 2017.
Category - Medicines Update
Tagged with - Guidelines Update

Heart MCN Key Message   All new initiations of sacubitril/valsartan must be discussed on an individual patient basis with a consultant with special interest in heart failure. For safety reasons, every patient commenced on...

Read More...

C diff infections and PPIs

Posted: April 25, 2017.
Category - Medicines Update
Tagged with - Antimicrobial Prescribing

There was an increase in Clostridium difficile infection (CDI) rates within NHSGGC in quarter 3 last year. A review of cases highlighted that almost half of the patients with CDI were prescribed a proton pump inhibitor ...

Read More...

Medicines Update Primary Care Supplement April 2017

Posted: April 20, 2017.
Category - Medicines Update Primary Care
Tagged with - Antimicrobial Prescribing Diabetes Dietetics Prescribing

To view this bulletin in PDF format please click here

This bulletin contains information on :

Primary Care Prescribing Intitiative

Read More...